625-633
Mini Review
Identification of type-specific anticancer histone deacetylase inhibitors: road to success
Nighat Noureen, Hamid Rashid and Saima Kalsoom
635-641
Original Article
Antitumor activity and pharmacokinetics of oral gimatecan on pediatric cancer xenografts
Massimo Zucchetti, Daniela Meco, Angela Maria Di Francesco, Tiziana Servidei and Valentina Patriarca, et al.
643-651
Original Article
Concurrent chemoradiation followed by adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma in Korea
Kyong Hwa Park, Jeong Sun Kim, Yong Park, Hee Yeon Seo and Young Je Park, et al.
653-658
Original Article
The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia
T. Adam de Beaumais, T. Dervieux, M. Fakhoury, Y. Medard and S. Azougagh, et al.
659-667
Original Article
Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy
Seung Tae Kim, Jeeyun Lee, Se Hoon Park, Joon Oh Park and Ho Yeong Lim, et al.
669-680
Original Article
Open AccessSunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
Francisco Robert, Alan Sandler, Joan H. Schiller, Glenn Liu and Karen Harper, et al.
681-689
Original Article
Down-regulation of heat shock protein 70 improves arsenic trioxide and 17-DMAG effects on constitutive signal transducer and activator of transcription 3 activity
Sampa Ghoshal, Indranil Rao, Justin C. Earp, William J. Jusko and Meir Wetzler
691-698
Original Article
Impact of functional ABCG2 polymorphisms on the adverse effects of gefitinib in Japanese patients with non–small-cell lung cancer
Keiichi Akasaka, Takayuki Kaburagi, Shin’ichi Yasuda, Kyoko Ohmori and Kaori Abe, et al.
699-707
Original Article
Pharmacokinetics of sunitinib malate in subjects with hepatic impairment
Carlo L. Bello, May Garrett, Laurie Sherman, John Smeraglia and Bob Ryan, et al.
709-719
Original Article
Corchorusin-D, a saikosaponin-like compound isolated from Corchorus acutangulus Lam., targets mitochondrial apoptotic pathways in leukemic cell lines (HL-60 and U937)
Sumana Mallick, Papiya Ghosh, Suman K. Samanta, Sumita Kinra and Bikas C. Pal, et al.
721-728
Original Article
Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
Yasushi Sato, Tetsuji Takayama, Tamotsu Sagawa, Yasuo Takahashi and Hiroyuki Ohnuma, et al.
729-736
Original Article
Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck
Mamoru Tsukuda, Junichi Ishitoya, Hideki Matsuda, Choichi Horiuchi and Takahide Taguchi, et al.
737-743
Original Article
Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors
Elizabeth Fox, John M. Maris, Susan L. Cohn, Wendy Goodspeed and Anne Goodwin, et al.
745-753
Original Article
Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice
Yasumichi Yagi, Sachio Fushida, Shinichi Harada, Tomoya Tsukada and Jun Kinoshita, et al.
755-764
Original Article
Inhibition of experimental colorectal cancer and reduction in renal and gastrointestinal toxicities by copper–indomethacin in rats
Antonio M. Bonin, Jaime A. Yáñez, Chie Fukuda, Xiao Wei Teng and Carolyn T. Dillon, et al.
765-771
Original Article
Open AccessPXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line
Stefan Harmsen, I. Meijerman, C. L. Febus, R. F. Maas-Bakker and J. H. Beijnen, et al.
773-783
Original Article
Intravenous paclitaxel against metastasis of human gastric tumors of diffuse type
Tsung-Fan Tuan, Meng-Li Tsai, Kai-Chia Yeh, Hsin-Chieh Huang and Cheng-Ta Chung, et al.
785-795
Original Article
Semi-mechanistic population pharmacokinetic/pharmacodynamic model for neutropenia following therapy with the Plk-1 inhibitor BI 2536 and its application in clinical development
Elena Soto, Alexander Staab, Christiane Tillmann, Dirk Trommeshauser and Holger Fritsch, et al.
797-805
Original Article
Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design
Yong Wha Moon, Sun Young Rha, Hei-Cheul Jeung, Chan Kim and Min Hee Hong, et al.
807-812
Short Communication
Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials
Tomasz Zaremba, Huw Thomas, Michael Cole, Elizabeth R. Plummer and Nicola J. Curtin
813-817
Short Communication
Pharmacokinetic analysis of carboplatin in patients with cancer who are undergoing hemodialysis
Tomoyo Oguri, Tomoya Shimokata, Megumi Inada, Isao Ito and Yuichi Ando, et al.